Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes?
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Fifty-seven highly recurrent unipolar patients, excluded from previous long-term studies with selective serotonin reuptake inhibitors (SSRIs) after they experienced a new recurrence, were acutely treated with the full dosage of the SSRIs they were on. Fifty-one of them (89.5%) had a sustained response and entered into the 4-month continuation therapy. During this phase, no relapse was observed. At the end of it, all patients gave their written informed consent to be enrolled in a 24-month long-term therapy, maintaining the same treatment dosage of fluvoxamine 300 mg/day, sertraline 150 mg/day, or paroxetine 40 mg/day. At the end of the study, 28 out of the 51 outpatients (54.9%) showed a further recurrence. Nevertheless, second recurrences observed during this second maintenance therapy were less severe than first recurrences, decreasing from 25.1+/-3.4 to 21.6+/-3.3 (P<0.0001), respectively. Considering the clinical characteristics of patients, we found that a high number of prior depressive episodes and an early age at onset of illness may predict a bad outcome. Moreover, patients with a longer duration of euthymia during a first maintenance period are less likely to have a new episode of depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, the presence of unaffected areas of psychological well-being may predict a more favorable clinical course [66].”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [66]
In the citing paper
“There is a wide variation in the characteristics of illness behavior in depressed patients [67] and in the response of both positive and negative schemas to treatment [66].”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [66]
Citations
Cites
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,297
Judd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Paulus, M. P., Kunovac, J. L., Leon, A. C., Mueller, T. I., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00138-4 · Cited by 590
Prevention of Recurrent Depression With Cognitive Behavioral Therapy: Preliminary Findings
Fava, G. A., Rafanelli, C., Grandi, S., Conti, S., & Belluardo, P. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.9.816 · Cited by 491
Prien, R. F. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200030104017 · Cited by 448
[Long-term treatment of depression].
Keller, M. B. (1994) · PubMed · Cited by 362
Langzeitbehandlung der Depression
Keller, M. B. (1994) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2007-1002360 · Cited by 362
Predictors of Relapse in Major Depressive Disorder
Keller, M. B. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03340240025024 · Cited by 306
Long-term treatment of depression.
Kupfer, D. J. (1991) · PubMed · Cited by 272
Relapse in Major Depressive Disorder: Analysis With the Life Table
Keller, M. B. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290080031005 · Cited by 260
Sertraline in the Prevention of Depression
Doogan, D. P., & Caillard, V. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.2.217 · Cited by 245
Cited by
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Can long-term treatment with antidepressant drugs worsen the course of depression?
Fava, G. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0204 · Cited by 223
“It is conceivable that this proportion would have increased with continuation of the trial, as was found to be the case in recurrent depression.(59) These data, therefore, strongly point to pharmacodynamic tolerance.”
ResultThe mechanisms of tolerance in antidepressant action
Fava, G. A., & Offidani, E. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.026 · Cited by 158
“It is conceivable that this percentage would have increased with continuation of the trial as was found to be the case in recurrent depression (Franchini et al., 2000).”
Riba, J., Anderer, P., Jané, F., Saletu, B., & Barbanoj, M. J. (2004) · Neuropsychobiology · doi:10.1159/000077946 · Cited by 148
Metadata
- Authors
- Franchini, L., Rossini, D., Bongiorno, F., Spagnolo, C., Smeraldi, E., & Zanardi, R.
- Affiliations
- University of Milan (IT)
- Corresponding author
- Franchini, Linda
- ORCID
- Zanardi, Raffaella
- Venue
- Psychiatry Research
- Publisher
- Elsevier BV
- Published
- 2000-09
- Volume
- 96
- Issue
- 1
- Pages
- 81-85
- ISSN
- 0165-1781 (ISSN-L)
- OpenAlex
- W2081715118
- Cited by
- 20
- References
- 27
- Citations by year
- 2024: 1 · 2021: 1 · 2020: 3 · 2018: 1 · 2015: 1 · 2014: 1
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Psychiatry Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- antidepressant prophylaxis, recurrent unipolar depression, selective serotonin reuptake inhibitors, fluvoxamine, sertraline, paroxetine, continuation treatment, relapse prevention, maintenance therapy, relapse severity
- MeSH terms
- Adult, Depressive Disorder, Dose-Response Relationship, Drug, Female, Humans, Male, Middle Aged, Risk Factors, Severity of Illness Index, Proportional Hazards Models, Fluvoxamine, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Paroxetine, Sertraline, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes? https://app.cochat.ai/papers/10.1016/s0165-1781(00)00188-8
- The paper
- Franchini, L., Rossini, D., Bongiorno, F., Spagnolo, C., Smeraldi, E., & Zanardi, R. (2000). Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes? Psychiatry Research. https://doi.org/10.1016/s0165-1781(00)00188-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.